United Kingdom· GB-APID-21973111000001108
Betmiga 50mg modified-release tablets
A mirabegron product containing mirabegron, registered in United Kingdom by Astellas Pharma Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Mirabegron is registered in 15 of 19 countries.
Countries holding a registration under ATC G04BD12 (mirabegron), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Mirabegron · ATC G04BD12
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mirabegron costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mirabegron · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.84
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mirabegron
- Manufacturer
- Astellas Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- G04BD12
- ATC class
- Mirabegron
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5013346075613
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
100 interactions on record for mirabegron.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mirabegron · interactions on record
100 records
- 3 severe
- 26 moderate
- 71 minor
Most severe, free to view
- EliglustatA16AX10severe
- VenetoclaxL01XX52severe
- TamoxifenL02BA01severe
- TrospiumA03AB20moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mirabegron in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBEGIRAXAristo Pharma GmbH, Berlin
- IcelandBegiraxAristo Pharma GmbH
- SpainBAXIRTO 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFGLaboratorios Alter S.A.
- PolandBegiraxAristo Pharma Sp. z o.o.
- FinlandBetmigaAstellas Pharma Europe B.V.
- NetherlandsBetmiga 50 mg, tabletten met verlengde afgifteAstellas Pharma Europe B.V.
- United StatesMirabegronZydus Pharmaceuticals (USA) Inc.
- IrelandBetmiga 50 mg prolonged-release tabletsAstellas Pharma Europe BV
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Mirabegron +pharma, Mirabegron G.L.
- Belgium · Mirabegron Eg, Mirabegron Teva
- Bulgaria · Иретиг, Мирабегрон G.L.
- Cyprus · Macitentan, Mirabegron
- Czechia · Begirax, Iretig
- Germany · Mirabegron Al, Mirabegron Aristo
- Denmark · Mirabegron Glenmark, Mirabegron Stada
- Estonia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
- Spain · Baxirto, Iretig
- Finland · Mirabegron Avansor, Mirabegron Glenmark
- France · Mirabegron Zentiva, Mirabegron Zentiva L.P.
- Greece · Iretig, Mirabegron Aristo Aristo
- Croatia · Iretig, Mezyran
- Hungary · Mirabegron Stada
- Ireland · Mirabegron Ascend, Mirabegron Clonmel
- Iceland · Betmiga, Iretig
- Italy · Iretig, Mirabegron Doc
- Liechtenstein · Betmiga
- Lithuania · Mirabegron Zentiva, Mirabegron Zentiva K.S.
- Luxembourg · Mirabegron Eg
- Latvia · Mirabegron Zentiva, Mirabegron Zentiva K.S.
- Malta · Mirabegron, Mirabegron Clonmel
- Netherlands · Mirabegron Cf, Mirabegron Glenmark
- Norway · Betmiga, Mirabegron Glenmark
- Poland · Begirax, Iretig
- Portugal · Baxirto, Mirabegrom Alter
- Romania · Iretig, Mirabegron G.L. Pharma
- Sweden · Mirabegron Avansor, Mirabegron Glenmark
- Slovenia · Gozi 25 Mg, Gozi 50 Mg
- Slovakia · Mirabegron Glenmark, Mirabegron Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b623a007-0e92-4abe-8dfe-edfc5aeb42bb GET /v1/drugs/b623a007-0e92-4abe-8dfe-edfc5aeb42bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "21973111000001108",
"desc": "Betmiga 50mg modified-release tablets (Astellas Pharma Ltd)",
"form": "Modified-release tablet",
"vpid": "38893511000001109",
"source": "dmd",
"vtm_id": "776802002",
"strength": "50 mg",
"substance": "Mirabegron",
"ingredient": "Mirabegron",
"supplier_code": "2066301000001100"
}See everything about mirabegron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.